INTERNATIONAL PATENT: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM FILES APPLICATION FOR "METHODS FOR SELECTING TRIPLE-NEGATIVE BREAST CANCER PATIENTS FOR TARGETED THERAPY USING TUMOR-SPECIFIC TOTAL MRNA EXPRESSION"

GENEVA, Aug. 26 -- BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (210 West 7th StreetAustin, Texas 78701) filed a patent application (PCT/US2025/015979) for "METHODS FOR SELECTING TRIPLE-NEGATIVE BREAST CANCER PATIENTS FOR TARGETED THERAPY USING TUMOR-SPECIFIC TOTAL MRNA EXPRESSION" on Feb 14, 2025. With publication no. WO/2025/175132, the details related to the patent application was published on Aug 21, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WANG, Wenyi (c/o UT MD Anderson Cancer Center1515 Holcombe Blvd.Houston, Texas 77030), DAI, Yaoyi (c/o UT MD Anderson Cancer Center1515 Ho...